English
简体中文
Total: £ 56.28
Published Date: 2026-03-12 | Pages: 112 | Tables: 115 | Medical Care
The global Cell-free Protein Synthesis market was valued at US$ 193 million in 2025 and is anticipated to reach US$ 298 million by 2032, at a CAGR of 6.4% from 2026 to 2032.
Cell-free protein synthesis is an in vitro protein production technology. This technology overcomes the limitations of traditional live cell culture by lysing cells to extract crude extracts containing ribosomes, polymerases, and translation factors, and supplementing these with substrates such as amino acids and energy substances to construct an in vitro protein synthesis system. Users only need to add a linear or circular DNA template to rapidly and controllably express the target protein. Its core advantages lie in its ability to express cytotoxic proteins, introduce non-natural amino acids, achieve high-throughput screening, and significantly shorten the synthesis cycle. It is widely used in structural biology, synthetic biology, and the development of clinical diagnostic reagents.
The global cell-free protein synthesis market is characterized by a three-way competition between the US, Asia, and Europe. North America, leveraging its early start, boasts several leading companies with core technologies, focusing on high-value-added applications such as high-throughput screening and membrane protein synthesis, and deeply integrating into synthetic biology automation platforms. Europe emphasizes the development of industrial enzymes and basic research tools, drawing on its strong foundation in structural biology and possessing unique strengths in radiolabeling and complex post-translational modification systems. Asia, represented by China and Japan, is experiencing rapid development, driving adoption in the education and research market through cost advantages, and accelerating its progress in point-of-care testing applications such as lyophilized formulations and portable biosensors.
This report delivers a comprehensive overview of the global Cell-free Protein Synthesis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell-free Protein Synthesis. The Cell-free Protein Synthesis market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell-free Protein Synthesis market comprehensively. Regional market sizes by Type, by Application, by Speed, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell-free Protein Synthesis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Thermo Fisher Scientific Inc.
New England Biolabs, Inc.
Promega Corporation
Takara Bio Inc.
CellFree Sciences Co., Ltd.
LenioBio GmbH
Nuclera Ltd.
Synthelis SAS
Profacgen
GeneCopoeia, Inc.
Bioneer Corporation
Daicel Arbor Biosciences
Merck KGaA
Segment by Type
E.Coli Cell-Free Protein Synthesis
Rabbit Reticulocytes Cell-Free Protein Synthesis
Wheat Germ Cell-Free Protein Synthesis
Insect Cells Cell-Free Protein Synthesis
Mammalian Cell-Free Protein Synthesis
Others
Segment by Speed
Batch Synthesis
Continuous Exchange/Dialysis Synthesis
Continuous Flow Synthesis
Segment by Purpose
High-Throughput Screening
Synthesis of Toxic/Difficult-to-Express Proteins
Incorporation of Non-natural Amino Acids
Others
Segment by Application
Pharmaceutical Companies
Academic/Research Institutes
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Speed, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell-free Protein Synthesis companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-free Protein Synthesis Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 E.Coli Cell-Free Protein Synthesis
1.2.3 Rabbit Reticulocytes Cell-Free Protein Synthesis
1.2.4 Wheat Germ Cell-Free Protein Synthesis
1.2.5 Insect Cells Cell-Free Protein Synthesis
1.2.6 Mammalian Cell-Free Protein Synthesis
1.2.7 Others
1.3 Market by Speed
1.3.1 Global Cell-free Protein Synthesis Market Size Growth Rate by Speed: 2021 vs 2025 vs 2032
1.3.2 Batch Synthesis
1.3.3 Continuous Exchange/Dialysis Synthesis
1.3.4 Continuous Flow Synthesis
1.4 Market by Purpose
1.4.1 Global Cell-free Protein Synthesis Market Size Growth Rate by Purpose: 2021 vs 2025 vs 2032
1.4.2 High-Throughput Screening
1.4.3 Synthesis of Toxic/Difficult-to-Express Proteins
1.4.4 Incorporation of Non-natural Amino Acids
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cell-free Protein Synthesis Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Pharmaceutical Companies
1.5.3 Academic/Research Institutes
1.5.4 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Cell-free Protein Synthesis Market Perspective (2021–2032)
2.2 Global Cell-free Protein Synthesis Growth Trends by Region
2.2.1 Global Cell-free Protein Synthesis Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell-free Protein Synthesis Historic Market Size by Region (2021–2026)
2.2.3 Cell-free Protein Synthesis Forecasted Market Size by Region (2027–2032)
2.3 Cell-free Protein Synthesis Market Dynamics
2.3.1 Cell-free Protein Synthesis Industry Trends
2.3.2 Cell-free Protein Synthesis Market Drivers
2.3.3 Cell-free Protein Synthesis Market Challenges
2.3.4 Cell-free Protein Synthesis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-free Protein Synthesis Players by Revenue
3.1.1 Global Top Cell-free Protein Synthesis Players by Revenue (2021–2026)
3.1.2 Global Cell-free Protein Synthesis Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell-free Protein Synthesis Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell-free Protein Synthesis Revenue
3.4 Global Cell-free Protein Synthesis Market Concentration Ratio
3.4.1 Global Cell-free Protein Synthesis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-free Protein Synthesis Revenue in 2025
3.5 Global Key Players of Cell-free Protein Synthesis Head Offices and Areas Served
3.6 Global Key Players of Cell-free Protein Synthesis, Products and Applications
3.7 Global Key Players of Cell-free Protein Synthesis, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell-free Protein Synthesis Breakdown Data by Type
4.1 Global Cell-free Protein Synthesis Historic Market Size by Type (2021–2026)
4.2 Global Cell-free Protein Synthesis Forecasted Market Size by Type (2027–2032)
5 Cell-free Protein Synthesis Breakdown Data by Application
5.1 Global Cell-free Protein Synthesis Historic Market Size by Application (2021–2026)
5.2 Global Cell-free Protein Synthesis Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell-free Protein Synthesis Market Size (2021–2032)
6.2 North America Cell-free Protein Synthesis Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell-free Protein Synthesis Market Size by Country (2021–2026)
6.4 North America Cell-free Protein Synthesis Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-free Protein Synthesis Market Size (2021–2032)
7.2 Europe Cell-free Protein Synthesis Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell-free Protein Synthesis Market Size by Country (2021–2026)
7.4 Europe Cell-free Protein Synthesis Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell-free Protein Synthesis Market Size (2021–2032)
8.2 Asia-Pacific Cell-free Protein Synthesis Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell-free Protein Synthesis Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell-free Protein Synthesis Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell-free Protein Synthesis Market Size (2021–2032)
9.2 Latin America Cell-free Protein Synthesis Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell-free Protein Synthesis Market Size by Country (2021–2026)
9.4 Latin America Cell-free Protein Synthesis Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-free Protein Synthesis Market Size (2021–2032)
10.2 Middle East & Africa Cell-free Protein Synthesis Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell-free Protein Synthesis Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell-free Protein Synthesis Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Cell-free Protein Synthesis Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 New England Biolabs, Inc.
11.2.1 New England Biolabs, Inc. Company Details
11.2.2 New England Biolabs, Inc. Business Overview
11.2.3 New England Biolabs, Inc. Cell-free Protein Synthesis Introduction
11.2.4 New England Biolabs, Inc. Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.2.5 New England Biolabs, Inc. Recent Development
11.3 Promega Corporation
11.3.1 Promega Corporation Company Details
11.3.2 Promega Corporation Business Overview
11.3.3 Promega Corporation Cell-free Protein Synthesis Introduction
11.3.4 Promega Corporation Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.3.5 Promega Corporation Recent Development
11.4 Takara Bio Inc.
11.4.1 Takara Bio Inc. Company Details
11.4.2 Takara Bio Inc. Business Overview
11.4.3 Takara Bio Inc. Cell-free Protein Synthesis Introduction
11.4.4 Takara Bio Inc. Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.4.5 Takara Bio Inc. Recent Development
11.5 CellFree Sciences Co., Ltd.
11.5.1 CellFree Sciences Co., Ltd. Company Details
11.5.2 CellFree Sciences Co., Ltd. Business Overview
11.5.3 CellFree Sciences Co., Ltd. Cell-free Protein Synthesis Introduction
11.5.4 CellFree Sciences Co., Ltd. Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.5.5 CellFree Sciences Co., Ltd. Recent Development
11.6 LenioBio GmbH
11.6.1 LenioBio GmbH Company Details
11.6.2 LenioBio GmbH Business Overview
11.6.3 LenioBio GmbH Cell-free Protein Synthesis Introduction
11.6.4 LenioBio GmbH Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.6.5 LenioBio GmbH Recent Development
11.7 Nuclera Ltd.
11.7.1 Nuclera Ltd. Company Details
11.7.2 Nuclera Ltd. Business Overview
11.7.3 Nuclera Ltd. Cell-free Protein Synthesis Introduction
11.7.4 Nuclera Ltd. Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.7.5 Nuclera Ltd. Recent Development
11.8 Synthelis SAS
11.8.1 Synthelis SAS Company Details
11.8.2 Synthelis SAS Business Overview
11.8.3 Synthelis SAS Cell-free Protein Synthesis Introduction
11.8.4 Synthelis SAS Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.8.5 Synthelis SAS Recent Development
11.9 Profacgen
11.9.1 Profacgen Company Details
11.9.2 Profacgen Business Overview
11.9.3 Profacgen Cell-free Protein Synthesis Introduction
11.9.4 Profacgen Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.9.5 Profacgen Recent Development
11.10 GeneCopoeia, Inc.
11.10.1 GeneCopoeia, Inc. Company Details
11.10.2 GeneCopoeia, Inc. Business Overview
11.10.3 GeneCopoeia, Inc. Cell-free Protein Synthesis Introduction
11.10.4 GeneCopoeia, Inc. Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.10.5 GeneCopoeia, Inc. Recent Development
11.11 Bioneer Corporation
11.11.1 Bioneer Corporation Company Details
11.11.2 Bioneer Corporation Business Overview
11.11.3 Bioneer Corporation Cell-free Protein Synthesis Introduction
11.11.4 Bioneer Corporation Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.11.5 Bioneer Corporation Recent Development
11.12 Daicel Arbor Biosciences
11.12.1 Daicel Arbor Biosciences Company Details
11.12.2 Daicel Arbor Biosciences Business Overview
11.12.3 Daicel Arbor Biosciences Cell-free Protein Synthesis Introduction
11.12.4 Daicel Arbor Biosciences Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.12.5 Daicel Arbor Biosciences Recent Development
11.13 Merck KGaA
11.13.1 Merck KGaA Company Details
11.13.2 Merck KGaA Business Overview
11.13.3 Merck KGaA Cell-free Protein Synthesis Introduction
11.13.4 Merck KGaA Revenue in Cell-free Protein Synthesis Business (2021–2026)
11.13.5 Merck KGaA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell-free Protein Synthesis Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of E.Coli Cell-Free Protein Synthesis
Table 3. Key Players of Rabbit Reticulocytes Cell-Free Protein Synthesis
Table 4. Key Players of Wheat Germ Cell-Free Protein Synthesis
Table 5. Key Players of Insect Cells Cell-Free Protein Synthesis
Table 6. Key Players of Mammalian Cell-Free Protein Synthesis
Table 7. Key Players of Others
Table 8. Global Cell-free Protein Synthesis Market Size Growth Rate by Speed (US$ Million): 2021 vs 2025 vs 2032
Table 9. Key Players of Batch Synthesis
Table 10. Key Players of Continuous Exchange/Dialysis Synthesis
Table 11. Key Players of Continuous Flow Synthesis
Table 12. Global Cell-free Protein Synthesis Market Size Growth Rate by Purpose (US$ Million): 2021 vs 2025 vs 2032
Table 13. Key Players of High-Throughput Screening
Table 14. Key Players of Synthesis of Toxic/Difficult-to-Express Proteins
Table 15. Key Players of Incorporation of Non-natural Amino Acids
Table 16. Key Players of Others
Table 17. Global Cell-free Protein Synthesis Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 18. Global Cell-free Protein Synthesis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Cell-free Protein Synthesis Market Size by Region (US$ Million), 2021–2026
Table 20. Global Cell-free Protein Synthesis Market Share by Region (2021–2026)
Table 21. Global Cell-free Protein Synthesis Forecasted Market Size by Region (US$ Million), 2027–2032
Table 22. Global Cell-free Protein Synthesis Market Share by Region (2027–2032)
Table 23. Cell-free Protein Synthesis Market Trends
Table 24. Cell-free Protein Synthesis Market Drivers
Table 25. Cell-free Protein Synthesis Market Challenges
Table 26. Cell-free Protein Synthesis Market Restraints
Table 27. Global Cell-free Protein Synthesis Revenue by Players (US$ Million), 2021–2026
Table 28. Global Cell-free Protein Synthesis Market Share by Players (2021–2026)
Table 29. Global Top Cell-free Protein Synthesis Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell-free Protein Synthesis Revenue, 2025
Table 30. Ranking of Global Top Cell-free Protein Synthesis Companies by Revenue (US$ Million) in 2025
Table 31. Global 5 Largest Players Market Share by Cell-free Protein Synthesis Revenue (CR5 and HHI), 2021–2026
Table 32. Global Key Players of Cell-free Protein Synthesis, Headquarters and Area Served
Table 33. Global Key Players of Cell-free Protein Synthesis, Products and Applications
Table 34. Global Key Players of Cell-free Protein Synthesis, Date of General Availability (GA)
Table 35. Mergers and Acquisitions, Expansion Plans
Table 36. Global Cell-free Protein Synthesis Market Size by Type (US$ Million), 2021–2026
Table 37. Global Cell-free Protein Synthesis Revenue Market Share by Type (2021–2026)
Table 38. Global Cell-free Protein Synthesis Forecasted Market Size by Type (US$ Million), 2027–2032
Table 39. Global Cell-free Protein Synthesis Revenue Market Share by Type (2027–2032)
Table 40. Global Cell-free Protein Synthesis Market Size by Application (US$ Million), 2021–2026
Table 41. Global Cell-free Protein Synthesis Revenue Market Share by Application (2021–2026)
Table 42. Global Cell-free Protein Synthesis Forecasted Market Size by Application (US$ Million), 2027–2032
Table 43. Global Cell-free Protein Synthesis Revenue Market Share by Application (2027–2032)
Table 44. North America Cell-free Protein Synthesis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 45. North America Cell-free Protein Synthesis Market Size by Country (US$ Million), 2021–2026
Table 46. North America Cell-free Protein Synthesis Market Size by Country (US$ Million), 2027–2032
Table 47. Europe Cell-free Protein Synthesis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 48. Europe Cell-free Protein Synthesis Market Size by Country (US$ Million), 2021–2026
Table 49. Europe Cell-free Protein Synthesis Market Size by Country (US$ Million), 2027–2032
Table 50. Asia-Pacific Cell-free Protein Synthesis Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 51. Asia-Pacific Cell-free Protein Synthesis Market Size by Region (US$ Million), 2021–2026
Table 52. Asia-Pacific Cell-free Protein Synthesis Market Size by Region (US$ Million), 2027–2032
Table 53. Latin America Cell-free Protein Synthesis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 54. Latin America Cell-free Protein Synthesis Market Size by Country (US$ Million), 2021–2026
Table 55. Latin America Cell-free Protein Synthesis Market Size by Country (US$ Million), 2027–2032
Table 56. Middle East & Africa Cell-free Protein Synthesis Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 57. Middle East & Africa Cell-free Protein Synthesis Market Size by Country (US$ Million), 2021–2026
Table 58. Middle East & Africa Cell-free Protein Synthesis Market Size by Country (US$ Million), 2027–2032
Table 59. Thermo Fisher Scientific Inc. Company Details
Table 60. Thermo Fisher Scientific Inc. Business Overview
Table 61. Thermo Fisher Scientific Inc. Cell-free Protein Synthesis Product
Table 62. Thermo Fisher Scientific Inc. Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 63. Thermo Fisher Scientific Inc. Recent Development
Table 64. New England Biolabs, Inc. Company Details
Table 65. New England Biolabs, Inc. Business Overview
Table 66. New England Biolabs, Inc. Cell-free Protein Synthesis Product
Table 67. New England Biolabs, Inc. Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 68. New England Biolabs, Inc. Recent Development
Table 69. Promega Corporation Company Details
Table 70. Promega Corporation Business Overview
Table 71. Promega Corporation Cell-free Protein Synthesis Product
Table 72. Promega Corporation Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 73. Promega Corporation Recent Development
Table 74. Takara Bio Inc. Company Details
Table 75. Takara Bio Inc. Business Overview
Table 76. Takara Bio Inc. Cell-free Protein Synthesis Product
Table 77. Takara Bio Inc. Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 78. Takara Bio Inc. Recent Development
Table 79. CellFree Sciences Co., Ltd. Company Details
Table 80. CellFree Sciences Co., Ltd. Business Overview
Table 81. CellFree Sciences Co., Ltd. Cell-free Protein Synthesis Product
Table 82. CellFree Sciences Co., Ltd. Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 83. CellFree Sciences Co., Ltd. Recent Development
Table 84. LenioBio GmbH Company Details
Table 85. LenioBio GmbH Business Overview
Table 86. LenioBio GmbH Cell-free Protein Synthesis Product
Table 87. LenioBio GmbH Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 88. LenioBio GmbH Recent Development
Table 89. Nuclera Ltd. Company Details
Table 90. Nuclera Ltd. Business Overview
Table 91. Nuclera Ltd. Cell-free Protein Synthesis Product
Table 92. Nuclera Ltd. Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 93. Nuclera Ltd. Recent Development
Table 94. Synthelis SAS Company Details
Table 95. Synthelis SAS Business Overview
Table 96. Synthelis SAS Cell-free Protein Synthesis Product
Table 97. Synthelis SAS Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 98. Synthelis SAS Recent Development
Table 99. Profacgen Company Details
Table 100. Profacgen Business Overview
Table 101. Profacgen Cell-free Protein Synthesis Product
Table 102. Profacgen Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 103. Profacgen Recent Development
Table 104. GeneCopoeia, Inc. Company Details
Table 105. GeneCopoeia, Inc. Business Overview
Table 106. GeneCopoeia, Inc. Cell-free Protein Synthesis Product
Table 107. GeneCopoeia, Inc. Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 108. GeneCopoeia, Inc. Recent Development
Table 109. Bioneer Corporation Company Details
Table 110. Bioneer Corporation Business Overview
Table 111. Bioneer Corporation Cell-free Protein Synthesis Product
Table 112. Bioneer Corporation Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 113. Bioneer Corporation Recent Development
Table 114. Daicel Arbor Biosciences Company Details
Table 115. Daicel Arbor Biosciences Business Overview
Table 116. Daicel Arbor Biosciences Cell-free Protein Synthesis Product
Table 117. Daicel Arbor Biosciences Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 118. Daicel Arbor Biosciences Recent Development
Table 119. Merck KGaA Company Details
Table 120. Merck KGaA Business Overview
Table 121. Merck KGaA Cell-free Protein Synthesis Product
Table 122. Merck KGaA Revenue in Cell-free Protein Synthesis Business (US$ Million), 2021–2026
Table 123. Merck KGaA Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
Table 127. Authors List of This Report
List of Figures
Figure 1. Cell-free Protein Synthesis Picture
Figure 2. Global Cell-free Protein Synthesis Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cell-free Protein Synthesis Market Share by Type: 2025 vs 2032
Figure 4. E.Coli Cell-Free Protein Synthesis Features
Figure 5. Rabbit Reticulocytes Cell-Free Protein Synthesis Features
Figure 6. Wheat Germ Cell-Free Protein Synthesis Features
Figure 7. Insect Cells Cell-Free Protein Synthesis Features
Figure 8. Mammalian Cell-Free Protein Synthesis Features
Figure 9. Others Features
Figure 10. Global Cell-free Protein Synthesis Market Size Comparison by Speed (US$ Million), 2021–2032
Figure 11. Batch Synthesis Features
Figure 12. Continuous Exchange/Dialysis Synthesis Features
Figure 13. Continuous Flow Synthesis Features
Figure 14. Global Cell-free Protein Synthesis Market Size Comparison by Purpose (US$ Million), 2021–2032
Figure 15. High-Throughput Screening Features
Figure 16. Synthesis of Toxic/Difficult-to-Express Proteins Features
Figure 17. Incorporation of Non-natural Amino Acids Features
Figure 18. Others Features
Figure 19. Global Cell-free Protein Synthesis Market Size by Application (US$ Million), 2021–2032
Figure 20. Global Cell-free Protein Synthesis Market Share by Application: 2025 vs 2032
Figure 21. Pharmaceutical Companies Case Studies
Figure 22. Academic/Research Institutes Case Studies
Figure 23. Others Case Studies
Figure 24. Cell-free Protein Synthesis Report Years Considered
Figure 25. Global Cell-free Protein Synthesis Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 26. Global Cell-free Protein Synthesis Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Cell-free Protein Synthesis Market Share by Region: 2025 vs 2032
Figure 28. Global Cell-free Protein Synthesis Market Share by Players in 2025
Figure 29. Global Cell-free Protein Synthesis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 30. The Top 10 and 5 Players Market Share by Cell-free Protein Synthesis Revenue in 2025
Figure 31. North America Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. North America Cell-free Protein Synthesis Market Share by Country (2021–2032)
Figure 33. United States Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Canada Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Europe Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Europe Cell-free Protein Synthesis Market Share by Country (2021–2032)
Figure 37. Germany Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. France Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. U.K. Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Italy Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Russia Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Ireland Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Asia-Pacific Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Asia-Pacific Cell-free Protein Synthesis Market Share by Region (2021–2032)
Figure 45. China Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Japan Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. South Korea Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Southeast Asia Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. India Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. Australia & New Zealand Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Latin America Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. Latin America Cell-free Protein Synthesis Market Share by Country (2021–2032)
Figure 53. Mexico Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Brazil Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Middle East & Africa Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 56. Middle East & Africa Cell-free Protein Synthesis Market Share by Country (2021–2032)
Figure 57. Israel Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Saudi Arabia Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 59. UAE Cell-free Protein Synthesis Market Size YoY Growth (US$ Million), 2021–2032
Figure 60. Thermo Fisher Scientific Inc. Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 61. New England Biolabs, Inc. Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 62. Promega Corporation Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 63. Takara Bio Inc. Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 64. CellFree Sciences Co., Ltd. Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 65. LenioBio GmbH Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 66. Nuclera Ltd. Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 67. Synthelis SAS Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 68. Profacgen Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 69. GeneCopoeia, Inc. Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 70. Bioneer Corporation Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 71. Daicel Arbor Biosciences Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 72. Merck KGaA Revenue Growth Rate in Cell-free Protein Synthesis Business (2021–2026)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
